We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants

Delisted

COEPW was delisted on the 24th of April, 2026.

13 hedge funds and large institutions have $9.72K invested in Coeptis Therapeutics Warrants in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1313 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.44% less ownership

Funds ownership: 2.5%2.06% (-0.44%)

54% less capital invested

Capital invested by funds: $21.4K → $9.72K (-$11.6K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
13
Holders Change
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

COEPW Hedge Fund Activity: Q1 2025 in Review

13 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q1 2025, worth a combined $9.72K — down 54% from $21.4K a quarter earlier.

Fund positioning in COEPW was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Osaic Holdings, opening a new position worth an estimated $458. The largest seller was Meteora Capital, cutting an estimated $4.58K.

  • 13 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $9.72K of Coeptis Therapeutics Warrants stock for Q1 2025, down 54% quarter-over-quarter.
  • 2 funds opened new Coeptis Therapeutics Warrants positions in Q1 2025 and 2 closed out, a net change of 0 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q1 2025 was Osaic Holdings, an estimated $458 added.
  • The largest Coeptis Therapeutics Warrants seller in Q1 2025 was Meteora Capital, an estimated $4.58K sold.

Based on aggregated 13F filings for Q1 2025.